IL17A and acute respiratory distress syndrome: In a minority of patients, a dysfunctional immune response occurs, leading to ARDS, multiorgan failure, and death, anticipated by the massive release of interleukin-17 (IL17), IL22, IL6, tumor necrosis factor-α (TNF), and other cytokines/chemokines.